Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
GHK-Cu stimulates angiogenesis primarily through upregulation of key growth factors including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF/FGF-2), with research demonstrating that GHK-Cu at nanomolar concentrations increases VEGF expression in dermal fibroblasts and stimulates human umbilical vein endothelial cell (HUVEC) proliferation through enhanced VEGF and FGF-2 expression
For adults who tolerate 2.4 mg for at least four weeks and need additional weight reduction, the current label allows a maximum of 7.2 mg weekly
Available from: Wu HHL, Wang AY
Patients interested in novel therapies like Survodutide, if approved, should consult healthcare professionals who can provide personalized guidance based on the latest research
